High-Leverage Financing and Support Ecosystem
/--/uploads/sites/4/2025/05/d5a9b33b80b48c451dfac8a5d36316605736be55.png)
/--/uploads/sites/4/2025/12/life-science.jpg)
Supportive ecosystem
Wallonia offers one of Europe’s most complete and collaborative financing environments for life sciences. Its ecosystem brings together public investors, private funds, international co- investors, and tailored support mechanisms, creating a high-leverage platform to fuel innovation and growth from start-up to scale-up.
Strong Public Anchors
Wallonia’s public investors — including Wallonie Entreprendre, Noshaq, Sambrinvest, Investsud, and Invest.BW — have co-financed over 130 companies across the region, providing flexible investment tickets from €0.5 million to €10 million, with room to go higher through syndication.
Together with SFPIM at the national level, these patient, catalytic investors back companies from seed to Series C+, co-investing alongside Belgian and international VCs, while offering long-term capital, strategic guidance, and sector expertise.
Comprehensive Grants and Support Tools
Innovators benefit from 50 to 80% public R&D funding coverage through the Walloon Administration for Research (grants and recoverable advances). Fiscal measures include tax incentives and payroll tax exemptions for researchers and R&D teams.
This is complemented by tailored support for innovation and internationalization, provided by partners such as BioWin, the Health cluster of Wallonia, and Wallonia Export & Investment Agency.
A Business-Friendly Environment
Combined with its dense network of biohubs, universities, incubators, and innovation clusters, this ecosystem ensures that life sciences companies can access the right capital, expertise, and support at every stage of their growth.
